Neurodegenerative diseases latest research and news. https://www.nature.com/subjects/neurodegenerative-diseases. Accessed 01 Oct 2022.
Moya-Alvarado G, Gershoni-Emek N, Perlson E, Bronfman F. Neurodegeneration and Alzheimer’s disease (ad). What can proteomics tell us about the Alzheimer’s brain? Mol Cell Proteom. 2016;15(2):409–25.
Article
CAS
Google Scholar
Duan R, Boland M, Liu Z, Liu Y, Chang H, Xu H, Chu H, Schmid C, Forrest C, Holmes J, Schuemie M, Berlin J, Moore J, Chen Y. Learning from electronic health records across multiple sites: a communication-efficient and privacy-preserving distributed algorithm. J Am Med Inf Assoc. 2020;27(3):376–85.
Article
Google Scholar
Ashburn T, Thor K. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004;3:673–83.
Article
CAS
Google Scholar
Kyungsoo P. A review of computational drug repurposing. Trans Clin Pharmacol. 2019;27(2):59–63. https://doi.org/10.12793/tcp.2019.27.2.59.
Article
Google Scholar
Pushpakom S, Iorio F, Eyers P, Escott K, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, Norris A, Sanseau P, Cavalla D, Pirmohamed M. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18(1):41–58.
Article
CAS
Google Scholar
Bonner S, Barrett I, Ye C, Swiers R, Engkvist O, Bender A, Hoyt C, Hamilton W. A review of biomedical datasets relating to drug discovery: a knowledge graph perspective. arXiv preprint arXiv:2102.10062 (2021)
Zhang R, Hristovski D, Schutte D, Kastrin A, Fiszman M, Kilicoglu H. Drug repurposing for COVID-19 via knowledge graph completion. J Biomed Inf. 2021;115: 103696.
Article
Google Scholar
Yan V, Li X, Ye X, Ou M, Luo R, Zhang Q, Tang B, BJ C, I H, Siu C, ICK W, RCK C, EW C. Drug repurposing for the treatment of COVID-19: a knowledge graph approach. Adv Ther (Weinh). 2021;4(10):2100179.
Al-Saleem J, Granet R, Ramakrishnan S, Ciancetta N, Saveson C, Gessner C, Zhou Q. Knowledge graph-based approaches to drug repurposing for COVID-19. J Chem Inf Model. 2021;61(8):4058–67. https://doi.org/10.1021/acs.jcim.1c00642 (PMID: 34297570).
Article
CAS
PubMed
Google Scholar
Sosa, D, Derry A, Guo M, Wei E, Brinton C, Altman R. A literature-based knowledge graph embedding method for identifying drug repurposing opportunities in rare diseases. Pac Symp Biocomput 2020; 25
Malas T, Vlietstra W, Kudrin R, Starikov S, Charrout M, Roos M, Peters D, Kors J, Vos R, PAC H, Mulligen E, Hettne K. Drug prioritization using the semantic properties of a knowledge graph. Sci Rep. 2019;9(1):6281.
Joseph J, Cole G, Head E, Ingram D. Nutrition, brain aging, and neurodegeneration. J Neurosci. 2009;29:12795–801.
Article
CAS
Google Scholar
PubMed. https://pubmed.ncbi.nlm.nih.gov/. Accessed 2022.
Rizvi R, Vasilakes J, Adam T, Melton G, Bishop J, Bian J, Tao C, Zhang R. iDISK: the integrated DIetary supplements knowledge base. J Am Med Inf Assoc. 2020;27(4):539–48.
Article
Google Scholar
Alisky JM. Intrathecal corticosteroids might slow Alzheimer’s disease progression. Neuropsychiatr Dis treat. 2008;45:831.
Article
Google Scholar
Devanand D, Andrews H, Kreisl W, Razlighi Q, Gershon A, Stern Y, Mintz A, Wisniewski T, Acosta E, Pollina J, Katsikoumbas M, Bell K, Pelton G, Deliyannides D, Prasad K, Huey E. Antiviral therapy: valacyclovir treatment of Alzheimer’s disease (valad) trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial. BMJ Open. 2020;10(2): e0321112.
Article
Google Scholar
Dodiya H, Frith M, Sidebottom A, Cao Y, Koval J, Chang E, Sisodia S. Synergistic depletion of gut microbial consortia, but not individual antibiotics, reduces amyloidosis in appps1-21 Alzheimer’s transgenic mice. Sci Rep. 2020;10:1–10.
Article
Google Scholar
A pilot open labeled study of tacrolimus in Alzheimer’s disease. https://clinicaltrials.gov/ct2/show/results/NCT04263519. Accessed 2022.
Alisky J. Intrathecal corticosteroids might slow Alzheimer’s disease progression. Neuropsychiatr Dis Treat. 2008;4(5):831.
Article
CAS
Google Scholar
Ricciarelli R, Fedele E. The amyloid cascade hypothesis in Alzheimer’s disease: it’s time to change our mind. Curr Neuropharmacol. 2017;15(6):926–35.
Article
CAS
Google Scholar
Dobarro M, Gerenu G, Ramírez M. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer’s transgenic mice. Int J Neuropsychopharmacol. 2013;16(10):2245–57.
Article
CAS
Google Scholar
Boutros S, Zimmerman B, Nagy S, Lee J, Perez R, Raber J. Amifostine (wr-2721) mitigates cognitive injury induced by heavy ion radiation in male mice and alters behavior and brain connectivity. Front Physiol. 2021. https://doi.org/10.3389/fphys.2021.770502.
Article
PubMed
PubMed Central
Google Scholar
Chai G-S, Jiang X, Ni Z-F, Ma Z-W, Xie A-J, Cheng X-S, Wang Q, Wang J-Z, Liu G-P. Betaine attenuates Alzheimer-like pathological changes and memory deficits induced by homocysteine. J Neurochem. 2013;3:388–96.
Article
Google Scholar
Mazurek M, Beal M, Bird E, Martin J. Oxytocin in Alzheimer’s disease: postmortem brain levels. Neurology. 1987;37(6):1001–1001.
Article
CAS
Google Scholar
Sureda A, Daglia M, Castilla S, Sanadgol N, Nabavi S, Khan H, Belwal T, Jeandet P, Marchese A, Pistollato F, Forbes-Hernandez T, Battino M, Berindan-Neagoe I, G D, Nabavi S. Oral microbiota and Alzheimer’s disease: Do all roads lead to rome?. Pharmacol Res. 2020;151:104582.
Li C, Yuan K, Schluesener H. Impact of minocycline on neurodegenerative diseases in rodents: a meta-analysis. Rev Neurosci. 2013;24(5):553–62.
Article
Google Scholar
Bortolanza M, Nascimento G, Socias S, Ploper D, Chehín R, Raisman-Vozari R, Del-Bel E. Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease. J Neural Transm (Vienna). 2018;125(10):1403–15.
Article
CAS
Google Scholar
Verma V, Bali A, Singh N, Jaggi A. Implications of sodium hydrogen exchangers in various brain diseases. J Basic Clin Physiol Pharmacol. 2015;26(5):417–26.
Article
CAS
Google Scholar
A study to determine the clinical safety/tolerability and exploratory efficacy of EHT 0202 as adjunctive therapy to acetylcholinesterase inhibitor in mild to moderate Alzheimer’s disease (EHT0202/002). https://clinicaltrials.gov/ct2/show/NCT00880412. Accessed 2022.
Fujimaki T, Saiki S, Tashiro E, Yamada D, Kitagawa M, Hattori N, Imoto M. Identification of licopyranocoumarin and glycyrurol from herbal medicines as neuroprotective compounds for parkinson’s disease. PLoS One. 2014;9(6): e100395.
Article
Google Scholar
Mei M, Zhou Y, Liu M, Zhao F, Wang C, Ding J, Lu M, Hu G. Antioxidant and anti-inflammatory effects of dexrazoxane on dopaminergic neuron degeneration in rodent models of parkinson’s disease. Neuropharmacology. 2019;160: 107758. https://doi.org/10.1016/j.neuropharm.2019.107758.
Article
CAS
PubMed
Google Scholar
Owona B, Zug C, Schluesener H, Zhang Z. Protective effects of Forskolin on behavioral deficits and neuropathological changes in a mouse model of cerebral amyloidosis. J Neuropathol Exp Neurol. 2016. https://doi.org/10.1093/jnen/nlw043.
Article
PubMed
PubMed Central
Google Scholar
Carreiras M, Ismaili L, Marco-Contelles J. Propargylamine-derived multi-target directed ligands for Alzheimer’s disease therapy. Bioorg Med Chem Lett. 2020;30(3): 126880.
Article
Google Scholar
Amit T, Bar-Am O, Mechlovich D, Kupershmidt L, Youdim MOW. The novel multitarget iron chelating and propargylamine drug m30 affects app regulation and processing activities in Alzheimer’s disease models. Neuropharmacology. 2017;123:359–67.
Article
CAS
Google Scholar
Ou H, Chien W, Chung C, Chang H, Kao Y, Wu P, Tzeng N. Association between antibiotic treatment of chlamydia pneumoniae and reduced risk of Alzheimer dementia: a nationwide cohort study in taiwan. Front Aging Neurosci. 2021. https://doi.org/10.3389/fnagi.2021.701899.
Article
PubMed
PubMed Central
Google Scholar
Angelucci F, Cechova K, Amlerova J, Hort J. Antibiotics, gut microbiota, and Alzheimer’s disease. J Neuroinflammation. 2019; 16108
Jaturapatporn D, Isaac M, McCleery J, Tabet N. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer’s disease. Cochrane Database Syst Rev. 2012;2:CD006378.
Google Scholar
Lara D, Cruz MR, Xavier F, Souza D, Moriguchi E. Allopurinol for the treatment of aggressive behaviour in patients with dementia. Int Clin Psychopharmacol. 2003;18:53–5.
PubMed
Google Scholar
Tikhonova MA, Amstislavskaya TG, Ho Y, Akopyan AA, Tenditnik MV, Ovsyukova MV, Bashirzade AA, Dubrovina NI, Aftanas LI. Neuroprotective effects of ceftriaxone involve the reduction of aβ burden and neuroinflammatory response in a mouse model of Alzheimer’s disease. Front Neurosci. 2021. https://doi.org/10.3389/fnins.2021.736786.
Article
PubMed
PubMed Central
Google Scholar
Fernando W, Stephanie R, Gardener S, Villemagne V, Burnham S, Macaulay SL, Brown B, Gupta VB, Sohrabi H, Weinborn M, Taddei K, Laws S, Goozee K, Ames D, Fowler C, Maruff P, Masters C, Salvado O, Rowe C, Martins R. Associations of dietary protein and fiber intake with brain and blood amyloid-β. J Alzheimers Dis. 2018;61(4):1589–98.
Article
CAS
Google Scholar
Kakutani S, Watanabe H, Murayama N. Green tea intake and risks for dementia, Alzheimer’s disease, mild cognitive impairment, and cognitive impairment: a systematic review. Nutrients. 2019. https://doi.org/10.3390/nu11051165.
Article
PubMed
PubMed Central
Google Scholar
Baranowska-Wójcik E, Szwajgier D, Winiarska-Mieczan A. Honey as the potential natural source of cholinesterase inhibitors in Alzheimer’s disease. Plant Foods Human Nutr. 2020;75(1):30–2.
Article
Google Scholar
Ylilauri M, Voutilainen S, Eija L, Virtanen HEK, Tuomainen T, Salonen J, Virtanen J. Associations of dietary choline intake with risk of incident dementia and with cognitive performance: the Kuopio Ischaemic heart disease risk factor study. Am J Clin Nutr. 2019;110:1416–23.
Article
Google Scholar
Vintimilla RM, Large SE, Gamboa A, Rohlfing GD, O’Jile JR, Hall JR, O’Bryant SE, Johnson LA. The link between potassium and mild cognitive impairment in Mexican-Americans. Dement Geriatr Cogn Dis Extra. 2018. https://doi.org/10.1159/000488483.
Article
PubMed
PubMed Central
Google Scholar
Okuda M, Fujita Y, Katsube T, Tabata H, Yoshino K, Hashimoto M, Sugimoto H. Highly water pressurized brown rice improves cognitive dysfunction in senescence-accelerated mouse prone 8 and reduces amyloid beta in the brain. BMC Complement Altern Med. 2018;68(1):110.
Article
Google Scholar
Eskelinen MH, Kivipelto M. Caffeine as a protective factor in dementia and Alzheimer’s disease. J Alzheimers Dis. 2010. https://doi.org/10.3233/JAD-2010-1404.
Article
PubMed
Google Scholar
Smalheiser NR. Ketamine: a neglected therapy for Alzheimer disease. Front Aging Neurosci. 2019. https://doi.org/10.3389/fnagi.2019.00186.
Article
PubMed
PubMed Central
Google Scholar
Hara Y, McKeehan N, Dacks PA, Fillit HM. Evaluation of the neuroprotective potential of n-acetylcysteine for prevention and treatment of cognitive aging and dementia. J Prev Alzheimers Dis. (2017)
Kilicoglu H, Shin D, Fiszman M, Rosemblat G, Rindflesch T. Semmeddb: a pubmed-scale repository of biomedical semantic predications. Bioinformatics. 2012;28(23):3158–60.
Article
CAS
Google Scholar
Kilicoglu H, Rosemblat G, Fiszman M, Shin D. Broad-coverage biomedical relation extraction with SemRep. BMC Bioinform. 2020;21:1–28.
Article
Google Scholar
McInnes BT. Extending the log-likelihood measure to improve collocation identification. Master’s thesis, Univerity of Minnesota, Minneapolis (2004)
Lin Y, Liu Z, Sun M, Liu Y, Zhu X. Learning entity and relation embeddings for knowledge graph completion. In: Proceedings of the Twenty-Ninth AAAI conference on artificial intelligence, AAAI’15, AAAI Press, Austin, Texas, 2015; pp. 2181–2187.
Zheng D, Song X, Ma C, Tan Z, Ye Z, Dong J, Xiong H, Zhang Z, Karypis G. Dgl-ke: Training knowledge graph embeddings at scale. In: Proceedings of the 43rd international ACM SIGIR conference on research and development in information retrieval. SIGIR ’20, Association for computing machinery, New York, NY, USA, 2020; pp. 739–748.
Bordes A, Usunier N, Garcia-Duran A, Weston J, Yakhnenko O. Translating embeddings for modeling multi-relational data 2013; 26
Yang B, Yih W, X H, Gao J, Deng L. Embedding entities and relations for learning and inference in knowledge bases (2015). arXiv:1412.6575
Trouillon T, Welbl J, Riedel S, Gaussier E, Bouchard G. Complex embeddings for simple link prediction (2016). arXiv:1606.06357
Henry S, McInnes BT. Literature based discovery: models, methods, and trends. J Biomed Inf. 2017;74:20–32. https://doi.org/10.1016/j.jbi.2017.08.011.
Article
Google Scholar